DGX
stock Healthcare Diagnostics & ResearchOverall Healthy · 78%
- Fundamentals Strong
- Trajectory Climbing
- Leadership Stable
A read across fundamentals, recent price & growth trajectory, and leadership stability. For fun and reading at a glance, not investment advice.
What the indicators say
Mixed 3 of 5 trend signals bullishRSI 51 — momentum is balanced between buyers and sellers.
A mechanical reading of the chart’s indicators — not investment advice.
Key statsas of Jun 3
- Open
- $193.70
- +0.28%
- Close
- $193.70
- +0.28%
- Current
- $193.70
- Prev close
- $193.16
- Today
- 416.32K
- 3-mo avg
- 879.89K
Earningscalendar synced from Yahoo 57d ago
- Most recent
- Apr 2191 days ago
- Next expected
- Jul 21in 0 days
Recent earnings dates
- Apr 21 91 days ago
- Feb 10 161 days ago
- Jan 12 190 days ago
- Oct 21, 2025 273 days ago
Past earnings dates come from DGX’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.
Fundamentalssynced from SEC 51d ago
Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), DGX’s fundamentals read as strong overall.
At 21.4x, the price is a reasonable multiple of the company's annual profit.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
This company pays no dividend, common for firms reinvesting their profits back into growth.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 9.0% margin is solid, in the ordinary range for a profitable company.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 13.8% return on equity is respectable, in the normal range.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 6.1% return on assets is reasonable for a company of this kind.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
Not enough data to compute debt-to-equity.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 1.04, short-term assets cover short-term bills with a little room to spare.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 11.8% from the prior year: strong top-line expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income grew 13.9% from the prior year: strong profit expansion.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financialssynced from SEC 51d ago
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $10.8B | $9.9B | $9.3B | $9.9B | $11.0B |
| Net income | $2.0B | $946.0M | $854.0M | $871.0M | $992.0M |
| Diluted EPS | $15.55 | $7.97 | $7.49 | $7.69 | $8.75 |
| Dividend / share | — | — | — | — | — |
| Total assets | $13.6B | $12.8B | $14.0B | $16.2B | $16.2B |
| Total liabilities | — | — | — | — | — |
| Shareholder equity | $6.5B | $5.9B | $6.3B | $6.8B | $7.2B |
| Q2-2024 | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.5B | $2.6B | $2.7B | $2.8B | $2.8B | $2.8B | $2.9B |
| Net income | $229.0M | $226.0M | $222.0M | $220.0M | $282.0M | $245.0M | $245.0M | $252.0M |
| Diluted EPS | $2.03 | $1.99 | $1.95 | $1.94 | $2.47 | $2.16 | $2.18 | $2.24 |
| Dividend / share | $0.75 | $0.75 | — | $0.80 | $0.80 | $0.80 | — | $0.86 |
Leadershipsynced from SEC 57d ago
- Carter Robert B Director
- Diaz Luis Director
- Doi Tracey Director
- Gregg Vicky B Director
- Lassiter Wright Iii Director
- Main Timothy L Director
- Morrison Denise M Director
- Pfeiffer Gary M Director
- Ring Timothy M Director
- Wentworth Timothy C Director
Officers and board are drawn from DGX’s recent SEC ownership filings (Forms 3, 4 and 5).
Recent leadership changes
Notable recent eventspast year
- Mar 12 Officer or director change reported in an 8-K
- Feb 10 +7.4% one-day move
- Jul 22, 2025 +7.1% one-day move
Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.
Dividendssynced from Yahoo 52d ago
- 2025 total
- $3.15
- 2026 so far
- $1.662 payments
- 2026 projected
- $3.32+5.4% vs 2025
Projection scales DGX’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.
Payment history
- Apr 6 $0.86
- Jan 13 $0.80
- Oct 3, 2025 $0.80
- Jul 7, 2025 $0.80
- Apr 7, 2025 $0.80
- Jan 14, 2025 $0.75
- Oct 4, 2024 $0.75
- Jul 8, 2024 $0.75
- Apr 5, 2024 $0.75
- Jan 16, 2024 $0.71
- Oct 5, 2023 $0.71
- Jul 10, 2023 $0.71
- Apr 6, 2023 $0.71
- Jan 17, 2023 $0.66
- Oct 3, 2022 $0.66
- Jul 5, 2022 $0.66
- Apr 5, 2022 $0.66
- Jan 18, 2022 $0.62
- Oct 4, 2021 $0.62
- Jul 6, 2021 $0.62
Recent SEC filingssynced from SEC 51d ago
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- DEF 14A Proxy statement
- 8-K Current report
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- DEF 14A Proxy statement